Claims for Patent: 9,295,462

Summary for Patent: 9,295,462

Title:	Suture comprising drug-loaded polymer layer and method of manufacturing the same
Abstract:	This invention relates to a suture including a drug-loaded polymer layer and a method of manufacturing the same, and more particularly, to a suture, the surface of which is wound with a film including a drug-loaded biodegradable polymer layer, or coated with a drug-loaded biodegradable polymer layer, and to a method of manufacturing the same.
Inventor(s):	Choy; Young Bin (Seongnam-si, KR), Heo; Chan Yeong (Yongin-si, KR), Lee; Ji Eun (Incheon, KR), Park; Su Bin (Seoul, KR)
Assignee:	SNU R&DB FOUNDATION (Seoul, KR)
Application Number:	13/304,460
Patent Claims:	1. A suture, comprising a suture and a film disposed in a winding manner around a surface of the suture, wherein the film comprises a drug-loaded biodegradable polymer layer in a form of a sheet, and the drug is present in a mixture with the biodegradable polymer within the drug-loaded polymer layer. 2. The suture of claim 1, wherein the film further comprises a biodegradable polymer layer having no drug, which is provided on the drug-loaded biodegradable polymer layer and functions as a drug diffusion barrier. 3. The suture of claim 1, wherein the drug is one or more of ibuprofen, aspirin, choline salicylate, celecoxib, diclofenac sodium, misoprostol, diflunisal, etodolac, fenoprofen calcium, flurbiprofen, indomethacin, ketoprofen, magnesium salicylate, mefenamic acid, meloxicam, nabumetone, naproxen, naproxen sodium, oxaprozin, piroxicam, rofecoxib, salsalate, sodium salicylate, sulindac, tolmetin sodium, valdecoxib, docetaxel, paclitaxel, tamoxifen, anasterozole, imatinib, floxuridine, leuprolide, zoledronate, flutamide, doxorubicin, vincristine, gemcitabine, streptozocin, prednisolone, deflazacort, cyclophosphamide, azathioprine, methotrexate, cyclosporine, tacrolimus, pirfenidone, mitomycin, 5-fluorouracil, Stratifin, acetylsalicylic acid, succinyl hydroxamates, selenocysteine, doxycycline, Osthole, genistein, Tranilast, Pseudolaric acid-B, tamoxifen(topical), halofuginone, vitamin C, nitrosylation derivatives of caspase-3, asiaticoside, 6-cyclohexyl-N-hydroxy-3-(1,2,4-oxadiazol-5-yl)hexanamides, Relaxin, Exchange protein activated by cAMP 1, daclizumab, bevacizumab, perfluorocarbons, antisense oligodeoxynucleotide, sodium carboxymethylcellulose, poly (gamma-glutamic acid), Necrox-5, Necrox-7, amniotic membrane extracts, onion extracts or garlic extracts. 4. The suture of claim 1, wherein the biodegradable polymer is polylactide (PLA), polyglycolide (PGA), poly(lactic-co-glycolic acid) (PLGA), polyorthoester, polyanhydride, polyamino acid, polyhydroxybutyric acid, polycaprolactone, polyalkylcarbonate, ethyl cellulose, chitosan, starch, guargum, gelatin, or collagen. 5. The suture of claim 1, wherein the film is adhered to the suture by treatment of heat or a solvent and wherein the solvent is selected from the group consisting of dichloromethane, chloroform, dimethylformamide, tetrahydrofuran, acetone, methylalcohol, ethylalcohol and combinations thereof. 6. A method of manufacturing a suture comprising the steps of: 1) preparing a film including a drug-loaded biodegradable polymer layer in a form of a sheet; and 2) winding the film including the drug-loaded biodegradable polymer layer around a surface of a suture. 7. The method of claim 6, wherein preparing the film including the drug-loaded biodegradable polymer layer in step 1) is performed by providing only a drug-loaded biodegradable polymer layer in film form, or by providing a drug-loaded biodegradable polymer layer in film form and then forming a biodegradable polymer layer having no drug on the drug-loaded biodegradable polymer layer. 8. The method of claim 6, further comprising applying heat or a solvent to the suture wound with the film so that the wound film is adhered to the suture, after step 2). 9. The method of claim 6, wherein the drug is one or more of ibuprofen, aspirin, choline salicylate, celecoxib, diclofenac sodium, misoprostol, diflunisal, etodolac, fenoprofen calcium, flurbiprofen, indomethacin, ketoprofen, magnesium salicylate, mefenamic acid, meloxicam, nabumetone, naproxen, naproxen sodium, oxaprozin, piroxicam, rofecoxib, salsalate, sodium salicylate, sulindac, tolmetin sodium, valdecoxib, docetaxel, paclitaxel, tamoxifen, anasterozole, imatinib, floxuridine, leuprolide, zoledronate, flutamide, doxorubicin, vincristine, gemcitabine, streptozocin, prednisolone, deflazacort, cyclophosphamide, azathioprine, methotrexate, cyclosporine, tacrolimus, pirfenidone, mitomycin, 5-fluorouracil, Stratifin, acetylsalicylic acid, succinyl hydroxamates, selenocysteine, doxycycline, Osthole, genistein, Tranilast, Pseudolaric acid-B, tamoxifen(topical), halofuginone, vitamin C, nitrosylation derivatives of caspase-3, asiaticoside, 6-cyclohexyl-N-hydroxy-3-(1,2,4-oxadiazol-5-yl)hexanamides, Relaxin, Exchange protein activated by cAMP 1, daclizumab, bevacizumab, perfluorocarbons, antisense oligodeoxynucleotide, sodium carboxymethylcellulose, poly (gamma-glutamic acid), Necrox-5, Necrox-7, amniotic membrane extracts, onion extracts or garlic extracts. 10. The method of claim 6, wherein the biodegradable polymer is polylactide (PLA), polyglycolide (PGA), poly(lactic-co-glycolic acid) (PLGA), polyorthoester, polyanhydride, polyamino acid, polyhydroxybutyric acid, polycaprolactone, polyalkylcarbonate, ethyl cellulose, chitosan, starch, guargum, gelatin, or collagen. 11. The method of claim 6, wherein the film including the polymer layer is formed using electrospinning or solution casting. 12. The method of claim 8, wherein the solvent is dichloromethane, chloroform, dimethylformamide, tetrahydrofuran, acetone, methylalcohol, ethylalcohol or combinations thereof.

Details for Patent 9,295,462

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Hoffmann-la Roche Inc.	ZENAPAX	daclizumab	Injection	103749	12/10/1997		2031-05-24
Genentech, Inc.	AVASTIN	bevacizumab	Injection	125085	02/26/2004		2031-05-24
Biogen Inc.	ZINBRYTA	daclizumab	Injection	761029	05/27/2016		2031-05-24
Biogen Inc.	ZINBRYTA	daclizumab	Injection	761029	05/26/2017		2031-05-24